Cargando…
FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) and prostate cancer (PCa) are among the most prevalent malignant tumors worldwide. There is now a comprehensive understanding of metabolic reprogramming as a hallmark of cancer. Fatty acid synthase (FASN) is a key regulator of the lipid metabolic n...
Autores principales: | Chianese, Ugo, Papulino, Chiara, Ali, Ahmad, Ciardiello, Fortunato, Cappabianca, Salvatore, Altucci, Lucia, Carafa, Vincenzo, Benedetti, Rosaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847120/ https://www.ncbi.nlm.nih.gov/pubmed/36650542 http://dx.doi.org/10.1186/s12967-023-03874-5 |
Ejemplares similares
-
Preclinical and Clinical Epigenetic-Based Reconsideration of Beckwith-Wiedemann Syndrome
por: Papulino, Chiara, et al.
Publicado: (2020) -
Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma
por: Ali, Ahmad, et al.
Publicado: (2022) -
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics
por: Chianese, Ugo, et al.
Publicado: (2022) -
Epigenetic mechanisms underlying prostate cancer radioresistance
por: Macedo-Silva, Catarina, et al.
Publicado: (2021) -
HDAC6 Inhibition Extinguishes Autophagy in Cancer: Recent Insights
por: Passaro, Eugenia, et al.
Publicado: (2021)